Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Booster HIV Drug Can Be Dropped

In a randomized trial, switching away from the booster drug allowed treatment-experienced patients to keep HIV under control and reduced toxicity, according to David Wohl, MD, of the University of North Carolina in Chapel Hill.

Published
13 September 2012
From
MedPage Today
'Berlin Man,' Doctor Convinced HIV Cure Is Real

The first person reportedly cured of HIV said Wednesday he is hopeful that medical advances will allow others suffering from the virus that causes AIDS to be cured, too.

Published
13 September 2012
From
ABC News
Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

An integrated analysis of data from phase II and III trials showed that the 'Quad' single-tablet regimen has antiviral efficacy at least as good as comparison regimens

Published
12 September 2012
By
Liz Highleyman
Combo Pills Fail to Get More HIV Patients on Meds

An insurance database study found that HIV-infected patients who were not adherent to taking any antiretrovirals behaved that way regardless of whether they received single-pill or multiple-pill regimens.

Published
12 September 2012
From
MedPage Today
Gladstone scientists develop technique to decipher the dormant AIDS virus concealed in cells

Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection -- by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

Published
12 September 2012
From
Eurekalert Medicine & Health
Long-acting fusion inhibitor albuvirtide looks promising in early studies

A new fusion inhibitor that prevents HIV entry into cells showed potent antiviral activity in early clinical studies and has a long half-life, suggesting it may be

Published
11 September 2012
By
Liz Highleyman
'Test And Treat' Strategy For Curbing HIV Draws Questions

Test and treat sounds good on paper, but some doctors and policymakers have doubts about its feasibility on a large scale.

Published
11 September 2012
From
NPR
High rate of infections in people with HIV receiving Bio-Alcamid treatment for facial lipoatrophy

Bio-Alcamid treatment for HIV-related lipoatrophy is associated with a high-rate of infectious complications, Canadian investigators report in the online edition of Clinical Infectious Diseases. The infections typically developed

Published
10 September 2012
By
Michael Carter
Salix Says FDA Decision Delayed on HIV-Associated Diarrhea Drug

Salix Pharmaceuticals Ltd. (SLXP), a maker of antibiotics and gastrointestinal drugs, said a decision by U.S. regulators on its new medicine to treat diarrhea in people with HIV has been postponed.

Published
06 September 2012
From
Bloomberg
High-End HIV Drug Stribild To Set Gilead Sciences Apart

As generic drugs take on an increasingly prominent role in the HIV/AIDS drug industry, it should be comforting to investors that Gilead Sciences (GILD) is still making intelligent moves to distance itself from its generic competitors.

Published
06 September 2012
From
Seeking Alpha

Filter by country